Skye Bioscience, Common Stock Market Value
| SKYE Stock | USD 2.86 0.15 4.98% |
| Symbol | Skye |
Skye Bioscience, Common Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Skye Bioscience,. If investors know Skye will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Skye Bioscience, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.60) | Return On Assets (0.30) | Return On Equity (0.55) |
The market value of Skye Bioscience, Common is measured differently than its book value, which is the value of Skye that is recorded on the company's balance sheet. Investors also form their own opinion of Skye Bioscience,'s value that differs from its market value or its book value, called intrinsic value, which is Skye Bioscience,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Skye Bioscience,'s market value can be influenced by many factors that don't directly affect Skye Bioscience,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Skye Bioscience,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Skye Bioscience, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Skye Bioscience,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Skye Bioscience, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Skye Bioscience,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Skye Bioscience,.
| 11/20/2024 |
| 12/20/2024 |
If you would invest 0.00 in Skye Bioscience, on November 20, 2024 and sell it all today you would earn a total of 0.00 from holding Skye Bioscience, Common or generate 0.0% return on investment in Skye Bioscience, over 30 days. Skye Bioscience, is related to or competes with Silo Pharma, Tonix Pharmaceuticals, Jaguar Animal, Vaxart, Revolution Medicines, Black Diamond, and Passage Bio. Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules ... More
Skye Bioscience, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Skye Bioscience,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Skye Bioscience, Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 47.58 | |||
| Value At Risk | (7.88) | |||
| Potential Upside | 9.46 |
Skye Bioscience, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Skye Bioscience,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Skye Bioscience,'s standard deviation. In reality, there are many statistical measures that can use Skye Bioscience, historical prices to predict the future Skye Bioscience,'s volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.61) | |||
| Total Risk Alpha | (0.81) | |||
| Treynor Ratio | (0.66) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Skye Bioscience,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Skye Bioscience, Common Backtested Returns
Skye Bioscience, Common owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0338, which indicates the firm had a -0.0338% return per unit of risk over the last 3 months. Skye Bioscience, Common exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Skye Bioscience,'s Coefficient Of Variation of (1,304), risk adjusted performance of (0.05), and Variance of 56.83 to confirm the risk estimate we provide. The entity has a beta of 0.89, which indicates possible diversification benefits within a given portfolio. Skye Bioscience, returns are very sensitive to returns on the market. As the market goes up or down, Skye Bioscience, is expected to follow. At this point, Skye Bioscience, Common has a negative expected return of -0.18%. Please make sure to validate Skye Bioscience,'s total risk alpha, as well as the relationship between the skewness and day median price , to decide if Skye Bioscience, Common performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.47 |
Average predictability
Skye Bioscience, Common has average predictability. Overlapping area represents the amount of predictability between Skye Bioscience, time series from 20th of November 2024 to 5th of December 2024 and 5th of December 2024 to 20th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Skye Bioscience, Common price movement. The serial correlation of 0.47 indicates that about 47.0% of current Skye Bioscience, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.47 | |
| Spearman Rank Test | 0.33 | |
| Residual Average | 0.0 | |
| Price Variance | 0.09 |
Skye Bioscience, Common lagged returns against current returns
Autocorrelation, which is Skye Bioscience, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Skye Bioscience,'s stock expected returns. We can calculate the autocorrelation of Skye Bioscience, returns to help us make a trade decision. For example, suppose you find that Skye Bioscience, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Skye Bioscience, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Skye Bioscience, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Skye Bioscience, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Skye Bioscience, stock over time.
Current vs Lagged Prices |
| Timeline |
Skye Bioscience, Lagged Returns
When evaluating Skye Bioscience,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Skye Bioscience, stock have on its future price. Skye Bioscience, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Skye Bioscience, autocorrelation shows the relationship between Skye Bioscience, stock current value and its past values and can show if there is a momentum factor associated with investing in Skye Bioscience, Common.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Skye Bioscience, Common is a strong investment it is important to analyze Skye Bioscience,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Skye Bioscience,'s future performance. For an informed investment choice regarding Skye Stock, refer to the following important reports:Check out Skye Bioscience, Correlation, Skye Bioscience, Volatility and Skye Bioscience, Alpha and Beta module to complement your research on Skye Bioscience,. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Skye Bioscience, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.